METTL3 and breast cancer: METTL3 promotes the development of colorectal cancer [17], gastric cancer [18], bladder cancer [19], breast cancer [20], renal cell carcinoma [21], and pancreatic cancer cells [22], and the occurrence of non-small cell lung cancer is related to METTL3 [23].